| Crosstalk between muscularis macrophages and enteric neurons regulates gastrointestinal motility PA Muller, B Koscsó, GM Rajani, K Stevanovic, ML Berres, D Hashimoto, ... Cell 158 (2), 300-313, 2014 | 659 | 2014 |
| BRAF-V600E expression in precursor versus differentiated dendritic cells defines clinically distinct LCH risk groups ML Berres, KPH Lim, T Peters, J Price, H Takizawa, H Salmon, J Idoyaga, ... Journal of Experimental Medicine 211 (4), 669-683, 2014 | 424 | 2014 |
| Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis R Chakraborty, OA Hampton, X Shen, SJ Simko, A Shih, H Abhyankar, ... Blood, The Journal of the American Society of Hematology 124 (19), 3007-3015, 2014 | 420 | 2014 |
| Dietary intake regulates the circulating inflammatory monocyte pool S Jordan, N Tung, M Casanova-Acebes, C Chang, C Cantoni, D Zhang, ... Cell 178 (5), 1102-1114. e17, 2019 | 332 | 2019 |
| Antagonism of the chemokine Ccl5 ameliorates experimental liver fibrosis in mice ML Berres, RR Koenen, A Rueland, MM Zaldivar, D Heinrichs, H Sahin, ... The Journal of clinical investigation 120 (11), 4129-4140, 2010 | 300 | 2010 |
| Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a … RK Kelley, M Ueno, C Yoo, RS Finn, J Furuse, Z Ren, T Yau, HJ Klümpen, ... The Lancet 401 (10391), 1853-1865, 2023 | 212 | 2023 |
| Antifibrotic effects of CXCL9 and its receptor CXCR3 in livers of mice and humans HE Wasmuth, F Lammert, MM Zaldivar, R Weiskirchen, C Hellerbrand, ... Gastroenterology 137 (1), 309-319. e3, 2009 | 205 | 2009 |
| Inhibition of hepatic fibrogenesis by matrix metalloproteinase‐9 mutants in mice M Roderfeld, R Weiskirchen, S Wagner, ML Berres, C Henkel, ... The FASEB journal 20 (3), 444-454, 2006 | 201 | 2006 |
| Progress in understanding the pathogenesis of Langerhans cell histiocytosis: back to Histiocytosis X? ML Berres, M Merad, CE Allen British journal of haematology 169 (1), 3-13, 2015 | 189 | 2015 |
| CXC chemokine ligand 4 (Cxcl4) is a platelet‐derived mediator of experimental liver fibrosis MM Zaldivar, K Pauels, P von Hundelshausen, ML Berres, P Schmitz, ... Hepatology 51 (4), 1345-1353, 2010 | 188 | 2010 |
| Macrophage migration inhibitory factor (MIF) exerts antifibrotic effects in experimental liver fibrosis via CD74 D Heinrichs, M Knauel, C Offermanns, ML Berres, A Nellen, L Leng, ... Proceedings of the National Academy of Sciences 108 (42), 17444-17449, 2011 | 172 | 2011 |
| Chemokine Cxcl9 attenuates liver fibrosis‐associated angiogenesis in mice H Sahin, E Borkham‐Kamphorst, C Kuppe, MM Zaldivar, C Grouls, ... Hepatology 55 (5), 1610-1619, 2012 | 149 | 2012 |
| Autophagy is a gatekeeper of hepatic differentiation and carcinogenesis by controlling the degradation of Yap YA Lee, LA Noon, KM Akat, MD Ybanez, TF Lee, ML Berres, N Fujiwara, ... Nature communications 9 (1), 4962, 2018 | 132 | 2018 |
| Pathological consequence of misguided dendritic cell differentiation in histiocytic diseases ML Berres, CE Allen, M Merad Advances in immunology 120, 127-161, 2013 | 93 | 2013 |
| Serum chemokine receptor CXCR3 ligands are associated with progression, organ dysfunction and complications of chronic liver diseases F Tacke, HW Zimmermann, ML Berres, C Trautwein, HE Wasmuth Liver International 31 (6), 840-849, 2011 | 93 | 2011 |
| Longitudinal monocyte human leukocyte antigen‐DR expression is a prognostic marker in critically ill patients with decompensated liver cirrhosis ML Berres, B Schnyder, E Yagmur, B Inglis, S Stanzel, JJW Tischendorf, ... Liver International 29 (4), 536-543, 2009 | 93 | 2009 |
| A functional variation in CHI3L1 is associated with severity of liver fibrosis and YKL-40 serum levels in chronic hepatitis C infection ML Berres, S Papen, K Pauels, P Schmitz, MM Zaldivar, C Hellerbrand, ... Journal of hepatology 50 (2), 370-376, 2009 | 90 | 2009 |
| Serum chemokine CXC ligand 10 (CXCL10) predicts fibrosis progression after liver transplantation for hepatitis C infection ML Berres, C Trautwein, M Schmeding, D Eurich, F Tacke, M Bahra, ... Hepatology 53 (2), 596-603, 2011 | 87 | 2011 |
| The fractalkine receptor CX3CR1 is involved in liver fibrosis due to chronic hepatitis C infection HE Wasmuth, MM Zaldivar, ML Berres, A Werth, D Scholten, S Hillebrandt, ... Journal of hepatology 48 (2), 208-215, 2008 | 83 | 2008 |
| Proapoptotic effects of the chemokine, CXCL 10 are mediated by the noncognate receptor TLR4 in hepatocytes H Sahin, E Borkham‐Kamphorst, NT do O, ML Berres, M Kaldenbach, ... Hepatology 57 (2), 797-805, 2013 | 70 | 2013 |
